The DOI matches its Crossref record; 243 of the 245 references it cites were found in a registry or an index.
Behavioral effects of neuropeptides in rodent models of depression and anxiety
Abstract
In recent years, studies have advocated neuropeptide systems as modulators for the behavioral states found in mood disorders such as depression and anxiety disorders. Neuropeptides have been tested in traditional animal models and screening procedures that have been validated by known antidepressants and anxiolytics. However, it has become clear that although these tests are very useful, neuropeptides have distinct behavioral effects and dose-dependent characteristics, and therefore, use of these tests with neuropeptides must be done with an understanding of their unique characteristics. This review will focus on the behavioral actions of neuropeptides and their synthetic analogs, particularly in studies utilizing various preclinical tests of depression and anxiety. Specifically, the following neuropeptide systems will be reviewed: corticotropin-releasing factor (CRF), urocortin (Ucn), teneurin C-terminal associated peptide (TCAP), neuropeptide Y (NPY), arginine vasopressin (AVP), oxytocin, the Tyr-MIF-1 family, cholecystokinin (CCK), galanin, and substance P. These neuropeptide systems each have a unique role in the regulation of stress-like behavior, and therefore provide intriguing therapeutic targets for mood disorder treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preclinical studies demonstrated that exogenous intravenous and intranasal oxytocin can influence fear related responses in rodents and monkeys respectively, reducing hiding behaviour during an open field test and attentional bias towards threatening facial expressions (Parr et al., 2013;Rotzinger et al., 2010).”
From Meta-analytic review of the effects of a single dose of intranasal oxytocin on threat processing in humans (2018) · cites this paper as Rotzinger et al., 2010
Citations
Cites
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Vale, W., Spiess, J., RIVIER, C. L., & Rivier, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Behavioural despair in rats: A new model sensitive to antidepressant treatments
Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90118-8 · Cited by 3,138
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Vaughan, J. M., Donaldson, C. J., Bittencourt, J. C., Perrin, M. H., Lewis, K., Sutton, S. W., Chan, R. K. W., Turnbull, A. V., Lovejoy, D. A., RIVIER, C. L., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479
Self-citation
Research works printed but not linked: 1
- Deak, 1999, The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress, Endocrinology, 140, 79, 10.1210/en.140.1.79 · DOI · Paper page
Cited by
Sorted by citations
The Effects of Psychological Stress on Depression
Yang, L., Zhao, Y., Wang, Y., Liu, L., Zhang, X., Li, B., & Cui, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x1304150831150507 · Cited by 589
Breaking the loop: Oxytocin as a potential treatment for drug addiction
McGregor, I. S., & Bowen, M. T. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.001 · Cited by 268
Cochran, D. M., Fallon, D., Hill, M., & Frazier, J. A. (2013) · Harvard Review of Psychiatry · doi:10.1097/hrp.0b013e3182a75b7d · Cited by 267
Stress, Endocrine Physiology and Pathophysiology -- Endotext
DeGroot, L. J., Chrousos, G. P., Dungan, K., Grossman, A. B., Jm, H., Koch, C., Korbonits, M., McLachlan, R., New, M., Purnell, J. Q., et al. (2000) · Europe PMC (PubMed Central) · Cited by 260
Comparative Analyses of Zebrafish Anxiety-Like Behavior Using Conflict-Based Novelty Tests
Kysil, E. V., Мешалкина, Д. А., Frick, E. E., Echevarria, D. J., Rosemberg, D. B., Maximino, C., Lima, M. G., de Abreu, M. S., Giacomini, A. C. V. V., Barcellos, L. J. G., et al. (2017) · Zebrafish · doi:10.1089/zeb.2016.1415 · Cited by 277
The endocannabinoid system in anxiety, fear memory and habituation
Ruehle, S., Rey, A. A., Remmers, F., & Lutz, B. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408958 · Cited by 236
Albers, H. E. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.07.001 · Cited by 200
The neuroendocrinology of primate maternal behavior
Wendy Saltzman, A., & Maestripieri, D. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.09.017 · Cited by 154
Sequeira‐Cordero, A., Salas-Bastos, A., Fornaguera, J., & Brenes, J. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-53624-1 · Cited by 151
Oxytocin׳s role in anxiety: A critical appraisal
MacDonald, K., & Feifel, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.025 · Cited by 139
Banasr, M., Lepack, A., Fee, C., Duric, V., Maldonado-Aviles, J., DiLeone, R., Sibille, E., Duman, R. S., & Sanacora, G. (2017) · Chronic Stress · doi:10.1177/2470547017720459 · Cited by 135
Exploring the role of neuropeptides in depression and anxiety
Rana, T., Behl, T., Sehgal, A., Singh, S., Sharma, N., Abdeen, A., Ibrahim, S. F., Mani, V., Iqbal, M. S., Bhatia, S., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110478 · Cited by 128
Sciolino, N. R., & Holmes, P. V. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.06.005 · Cited by 118
Huang, H.-J., Zhu, X.-C., Han, Q.-Q., Wang, Y.-L., Yue, N., Wang, J., Yu, R., Li, B., Wu, G.-C., Liu, Q., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.02.040 · Cited by 114
Sabihi, S., Durosko, N. E., Dong, S. M., & Leuner, B. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.009 · Cited by 106
Holt-Lunstad, J., Birmingham, W., & Light, K. C. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.03.007 · Cited by 103
High plasma nesfatin-1 level in patients with major depressive disorder
Arı, M., Öztürk, O. H., Bez, Y., Oktar, S., & Erduran, D. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.004 · Cited by 105
Sabihi, S., Dong, S. M., Durosko, N. E., & Leuner, B. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00258 · Cited by 101
Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103
“Of course, the animal models are not the perfect representation of the complex human diseases, especially considering the fact that psychiatric concepts such as self-esteem, recurrent thoughts of death [162], or fear of losing control [163] are not reproducible in this case.”
BackgroundChristiansen, S. H., Olesen, M. V., Wörtwein, G., & Woldbye, D. P. D. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.044 · Cited by 103
Neuropeptidergic Signaling Partitions Arousal Behaviors in Zebrafish
Woods, I. G., Schoppik, D., Shi, V. J., Zimmerman, S., Coleman, H. A., Greenwood, J. S. F., Soucy, E. R., & Schier, A. F. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3529-13.2014 · Cited by 100
Effects of early life social stress on maternal behavior and neuroendocrinology
Murgatroyd, C., & Nephew, B. C. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.05.020 · Cited by 100
Hansson, C., Haage, D., Taube, M., Egecioglu, E., Salomé, N., & Dickson, S. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.002 · Cited by 105
Shi, H., Zhu, W., Liu, J., Luo, Y., Si, J., Wang, S., Xue, Y.-X., Ding, Z., Shi, J., & Lü, L. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.131 · Cited by 96
Curley, J. P., Jensen, C. L., Franks, B., & Champagne, F. A. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.01.013 · Cited by 97
Phylogenetic Analysis of the Teneurins: Conserved Features and Premetazoan Ancestry
Tucker, R. P., Beckmann, J., Leachman, N. T., Schöler, J., & Chiquet‐Ehrismann, R. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr271 · Cited by 91
Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention
Nollet, M., & Leman, S. (2013) · CNS Drugs · doi:10.1007/s40263-013-0064-z · Cited by 89
Ayers, L. W., Missig, G., Schulkin, J. A., & Rosen, J. B. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.138 · Cited by 87
The Role of Clock in Ethanol-Related Behaviors
Ozburn, A. R., Falcón, E., Mukherjee, S., Gillman, A. G., Arey, R. N., Spencer, S. M., & McClung, C. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.138 · Cited by 86
The mechanism of electroacupuncture for depression on basic research: a systematic review
Han, X., Gao, Y., Yin, X., Zhang, Z., Lao, L., Chen, Q., & Xu, S. (2021) · Chinese Medicine · doi:10.1186/s13020-020-00421-y · Cited by 87
Sabihi, S., Dong, S. M., Maurer, S., Goodpaster, C. M., & Leuner, B. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.024 · Cited by 87
Oxytocin Reduces Background Anxiety in a Fear-Potentiated Startle Paradigm
Missig, G., Ayers, L. W., Schulkin, J., & Rosen, J. B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.155 · Cited by 79
Hypothalamus and Post-Traumatic Stress Disorder: A Review
Raise‐Abdullahi, P., Meamar, M., Vafaei, A. A., Alizadeh, M., Dadkhah, M., Shafia, S., Ghalandari-Shamami, M., Naderian, R., Samaei, A., & Rashidy‐Pour, A. (2023) · Brain Sciences · doi:10.3390/brainsci13071010 · Cited by 84
Role of 5-HT3 Receptors in the Antidepressant Response
Betry, C., Etiévant, A., Oosterhof, C. A., Ebert, B., Sánchez, C., & Haddjeri, N. (2011) · Pharmaceuticals · doi:10.3390/ph4040603 · Cited by 81
Smith, C. M., Walker, A. W., Hosken, I. T., Chua, B. E., Zhang, C., Haidar, M., & Gundlach, A. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00046 · Cited by 69
Sánchez-Vidaña, D. I., Chan, N.-M. J., Chan, A. H. L., Hui, K. K. Y., Lee, S. Y., Chan, H.-Y., Law, Y. S., Sze, M. Y., Tsui, W.-C. S., Fung, T. K. H., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.005 · Cited by 71
Morales‐Medina, J. C., Dumont, Y., Benoit, C.-É., Bastianetto, S., Flores, G., Fournier, A., & Quirion, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.030 · Cited by 70
May oxytocin be a trait marker for bipolar disorder?
Turan, T., Uysal, C., Asdemir, A., & Kılıç, E. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.07.017 · Cited by 66
Behavioral effect of neuropeptides related to feeding regulation in fish
Matsuda, K., Kang, K. S., Sakashita, A., Yahashi, S., & Vaudry, H. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05884.x · Cited by 65
Davidson, S., Lear, M., Shanley, L. J., Hing, B. W. Q., Baizan-Edge, A., Herwig, A., Quinn, J. P., Breen, G. D., McGuffin, P., Starkey, A. J., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.93 · Cited by 65
Lach, G., & de Lima, T. C. M. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.04.005 · Cited by 64
Kumar, J. R., Rajkumar, R., Jayakody, T., Marwari, S., Hóng, J., Ma, S., Gundlach, A. L., Lai, M. K. P., & Dawe, G. S. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13564 · Cited by 63
Neurobiological consequences of juvenile stress: A GABAergic perspective on risk and resilience
Albrecht, A., Müller, I., Ardi, Z., Çalışkan, G., Gruber, D., Ivens, S., Segal, M., Behr, J., Heinemann, U., Stork, O., et al. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.005 · Cited by 65
Shi, D.-D., Zhang, Y.-D., Ren, Y.-Y., Peng, S.-Y., Yuan, T.-F., & Wang, Z. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01293-w · Cited by 63
Hofmann, T., Elbelt, U., Ahnis, A., Rose, M., Klapp, B. F., & Stengel, A. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.06.014 · Cited by 63
MOLECULAR EVOLUTION OF GPCRS: CRH/CRH receptors
Lovejoy, D. A., Chang, B. S. W., Lovejoy, N. R., & del Castillo, J. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0238 · Cited by 63
Self-citationArey, R. N., Enwright, J. F., Spencer, S. M., Falcon, E., Ozburn, A. R., Ghose, S., Tamminga, C., & McClung, C. A. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.12 · Cited by 62
On the Teneurin track: a new synaptic organization molecule emerges
Mosca, T. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00204 · Cited by 61
Del Boca, C., Lutz, P. E., Le Merrer, J., Koebel, P., & Kieffer, B. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.022 · Cited by 59
Ida, T., Takahashi, T., Tominaga, H., Sato, T., Kume, K., Ozaki, M., Hiraguchi, T., Maeda, T., Shiotani, H., Terajima, S., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.081 · Cited by 58
Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder
Gunay, H., Tutuncu, R., Aydın, S., Dağ, E., & Abaslı, D. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.04.007 · Cited by 58
Anxiety and Depression: What Do We Know of Neuropeptides?
Kupcová, I., Danišovič, Ľ., Grgac, I., & Harsányi, Š. (2022) · Behavioral Sciences · doi:10.3390/bs12080262 · Cited by 62
Doosti, M.-H., Bakhtiari, A., Zare, P., Amani, M., Zolbanin, N. M., Babri, S., & Salari, A. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.003 · Cited by 57
Relaxin-3-Deficient Mice Showed Slight Alteration in Anxiety-Related Behavior
Watanabe, Y., Tsujimura, A., Takao, K., Nishi, K., Ito, Y., Yasuhara, Y., Nakatomi, Y., Yokoyama, C., Fukui, K., Miyakawa, T., et al. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00050 · Cited by 56
Massey, S. H., Backes, K. A., & Schuette, S. (2016) · Depression and Anxiety · doi:10.1002/da.22467 · Cited by 53
Kang, K. S., Yahashi, S., & Matsuda, K. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.006 · Cited by 47
Leppanen, J., Ng, K. W., Kim, Y.-R., Tchanturia, K., & Treasure, J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.041 · Cited by 45
Jlalia, I., Lensen, N., Chaume, G., Dzhambazova, E. B., Astasidi, L., Tafradjiiska-Hadjiolova, R. K., Bocheva, A. I., & Brigaud, T. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.041 · Cited by 45
The role of orexin in post-stroke inflammation, cognitive decline, and depression
Song, J., Kim, E., Kim, C. H., Song, H., & Lee, J. E. (2015) · Molecular Brain · doi:10.1186/s13041-015-0106-1 · Cited by 49
Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects
Naja, W., & Aoun, M. P. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0819-1 · Cited by 42
Bodkin, J. V., Thakore, P., Aubdool, A. A., Liang, L., Fernandes, E. S., Nandi, M., Spina, D., Clark, J., Aaronson, P. I., Shattock, M. J., et al. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.52 · Cited by 41
Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor
Wu, X., Hsuchou, H., Kastin, A. J., He, Y., Khan, R. S., Stone, K. P., Cash, M. S., & Pan, W. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.017 · Cited by 41
Murphy, M., & Mercer, J. G. (2013) · International Journal of Endocrinology · doi:10.1155/2013/701967 · Cited by 44
Chand, D. S., Casatti, C. A., de Lannoy, L., Song, L., Kollara, A., Baršytė-Lovejoy, D., Brown, T. J., & Lovejoy, D. A. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.09.006 · Cited by 40
Self-citationKagawa, N. (2012) · Journal of Fish Biology · doi:10.1111/j.1095-8649.2012.03490.x · Cited by 39
Oxytocin Signaling Pathway: From Cell Biology to Clinical Implications
Iovino, M., Messana, T., Tortora, A., Giusti, C., Lisco, G., Giagulli, V. A., Guastamacchia, E., Pergola, G. D., & Triggiani, V. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200520093730 · Cited by 39
Kyeremanteng, C., MacKay, J. C., James, J. S., Kent, P., Cayer, C., Anisman, H., & Merali, Z. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.05.012 · Cited by 37
Substance P receptor antagonist in lateral habenula improves rat depression-like behavior
Yang, L.-M., Yu, L., Jin, H., & Zhao, H. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.10.007 · Cited by 36
The Role of the PACAP Signaling System in Depression
Pinhasov, A., Nesher, E., Gross, M., Turgeman, G., Kreinin, A., & Yadid, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795589328 · Cited by 37
Bardi, M., Rhone, A. P., Franssen, C. L., Hampton, J. E., Shea, E. A., Hyer, M. M., Huber, J., & Lambert, K. G. (2012) · Stress · doi:10.3109/10253890.2011.623739 · Cited by 38
Gelfo, F., Tirassa, P., Bartolo, P. D., Croce, N., Bernardini, S., Caltagirone, C., Petrosini, L., & Angelucci, F. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00314.x · Cited by 36
Narváez, M., Millón, C., Borroto‐Escuela, D. O., Flores‐Burgess, A., Santín, L. J., Parrado, C., Gago, B., Puigcerver, A., Fuxé, K., Narváez, J. Á., et al. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0788-7 · Cited by 36
The Role of Neuropeptide Y in the Nucleus Accumbens
Tanaka, M., Yamada, S., & Watanabe, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147287 · Cited by 35
Antunes, M. S., Ruff, J. R., Janner, D. E., Piêgas, M. B., de Brito, M. L. O., Rocha, K. M. A., de Gomes, M. G., Goes, A. T. R., Souza, L. C., Donato, F., et al. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.05.018 · Cited by 34
Wendy Saltzman, A., Boettcher, C., Post, J., & Abbott, D. H. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02153.x · Cited by 33
Anticonvulsant neuropeptides as drug leads for neurological diseases
Robertson, C. R., Flynn, S. P., White, H. S., & Bulaj, G. W. (2011) · Natural Product Reports · doi:10.1039/c0np00048e · Cited by 33
Pastor, R., Reed, C. L., Burkhart‐Kasch, S., Li, N., Sharpe, A. L., Coste, S. C., Stenzel‐Poore, M. P., & Phillips, T. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2284-6 · Cited by 33
Boxelaere, M. V., Clements, J., Callaerts, P., D’Hooge, R., & Callaerts‐Vegh, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188537 · Cited by 34
Nakamachi, T., Shibata, H., Sakashita, A., Iinuma, N., Wada, K., Konno, N., & Matsuda, K. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.06.004 · Cited by 31
Urocortin 2 modulates aspects of social behaviour in mice
Breu, J., Touma, C., Hölter, S. M., Knapman, A., Wurst, W., & Deussing, J. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.05.031 · Cited by 30
Rohwedder, A., Selcho, M., Chassot, B., & Thum, A. S. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23873 · Cited by 32
Effects of environmental manipulations in genetically targeted animal models of affective disorders
Renoir, T., Pang, T. Y., & Hannan, A. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.04.003 · Cited by 32
Ogłodek, E. A., Just, M. J., Szromek, A. R., & Araszkiewicz, A. S. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.04.013 · Cited by 29
The octadecaneuropeptide exerts an anxiogenic-like action in goldfish
Matsuda, K., Wada, K., Azuma, M., Leprince, J., Tonon, M., Sakashita, A., Maruyama, K., Uchiyama, M., & Vaudry, H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.058 · Cited by 29
Shi, H., Yin, X., Song, L., Guo, Q., & Luo, X.-H. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.051 · Cited by 29
Kagawa, N. (2014) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.31.116 · Cited by 29
Coverdill, A. J., McCarthy, M., Bridges, R. S., & Nephew, B. C. (2012) · Brain Sciences · doi:10.3390/brainsci2040589 · Cited by 27
Marie-Luce, C., Raskin, K., Bolborea, M., Monin, M., Picot, M., & Mhaouty‐Kodja, S. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.03.031 · Cited by 34
On the Role of Cholecystokinin (CCK) in Fear and Anxiety: A Review and Research Proposal
Crespi, F. (2019) · Journal of Human Psychology · doi:10.14302/issn.2644-1101.jhp-19-2766 · Cited by 26
Circadian Modulation of Anxiety: A Role for Somatostatin in the Amygdala
Albrecht, A., Thiere, M., Bergado-Acosta, J. R., Poranzke, J., Müller, B., & Stork, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084668 · Cited by 26
The Neurokinin-1 Receptor in Addictive Processes
Schank, J. R. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.210799 · Cited by 26
The Effects of Ghrelin on Energy Balance and Psychomotor Activity in a Goldfish Model: An Overview
Kang, K. S., Yahashi, S., & Matsuda, K. (2011) · International Journal of Peptides · doi:10.1155/2011/171034 · Cited by 26
Plasma Nesfatin-1 Level May Be Associated with Disease Severity in Patients with Panic Disorder
Bez, Y., Arı, M., Öztürk, O. H., Oktar, S., Can, Y., & Söğüt, S. (2010) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.1080/10177833.2010.11790674 · Cited by 26
Williams, S. K., & Johns, J. M. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.004 · Cited by 26
Erb, S. M., McPhee, M. D., Brown, Z. J., Kupferschmidt, D. A., Song, L., & Lovejoy, D. A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.013 · Cited by 24
Self-citationJawad, M., Shafique, U., Din, F. U., Butt, A., Khan, S., Khan, G. M., Alamri, A. H., Lahiq, A. A., Alsharif, S. T., & Almerai, K. S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105800 · Cited by 23
Nakazawa, C. M., Shikata, K., Uesugi, M., Katayama, H., Aoshima, K., Tahara, K., Takahashi, E., Hida, T., Shibata, H., Ogura, H., et al. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2012.756895 · Cited by 23
Matsuda, K., Hagiwara, Y., Shibata, H., Sakashita, A., & Wada, K. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.01.001 · Cited by 23
The Role of Endogenous Oxytocin in Anxiolysis: Structural and Functional Correlates
Lancaster, K., Goldbeck, L., Pournajafi‐Nazarloo, H., Connelly, J. J., Carter, C. S., & Morris, J. P. (2017) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.10.003 · Cited by 24
Lancaster, K., Goldbeck, L., Puglia, M. H., Morris, J. P., & Connelly, J. J. (2018) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsy086 · Cited by 25
Metadata
- Authors
- Rotzinger, S., Lovejoy, D. A., & Tan, L. A.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Tan, Laura A.
- Venue
- Peptides
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 31
- Issue
- 4
- Pages
- 736-756
- ISSN
- 0196-9781 (ISSN-L)
- OpenAlex
- W2087834131
- Cited by
- 211
- References
- 245
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 8 · 2023: 5 · 2022: 10 · 2021: 6 · 2020: 6 · 2019: 8 · 2018: 9 · 2017: 14 · 2016: 10 · 2015: 12 · 2014: 21 · 2013: 24 · 2012: 27
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Peptides (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (FRN 72027622)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- neuropeptides, depression, anxiety, mood disorders, corticotropin-releasing factor, urocortin, neuropeptide Y, vasopressin, oxytocin, cholecystokinin, galanin, substance P, antidepressant screening, rodent models, therapeutic target
- MeSH terms
- Animals, Anxiety, Arginine Vasopressin, Behavior, Animal, Cholecystokinin, Corticotropin-Releasing Hormone, Depression, Disease Models, Animal, Humans, MSH Release-Inhibiting Hormone, Neuropeptide Y, Neuropeptides, Neuropsychological Tests, Oxytocin, Social Behavior, Galanin, Urocortins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review